Effective Competitive Intelligence: A ``How-To`` Guide for Life Science Companies

Effective Competitive Intelligence: A ``How-To`` Guide for Life Science Companies
  • Report price : $ 499
  • Publication date : November 2008

Get this Report Now !

Effective Competitive Intelligence: A ``How-To`` Guide for Life Science Companies



Often what separates successful marketing from bad is good competitive intelligence. This is true in life sciences as much as other industries. Many companies approach CI in a way that is unplanned, indirect and harmful to their business. But how does one know if they are conducting their company's CI in the best way?

If you are trying to determine how to use competitive intelligence better, if you are attempting to judge your efforts compared to companies that have been successful, and if you want to know what computer resources might assist you, this guide can help. If you want to get more attention for CI in your organization, and develop a professional and worthwhile approach, this guide is the most useful, current and relevant published on the subject.

Prepared by Dr. Laura Ruth, PhD and the experts at Fuld & Company, jointly published with Kalorama Information, a premier life sciences market research publisher, can assist executives in the life science tasked with implementing competitive intelligence activities.

The utility and power of competitive intelligence for improving decision-making for strategy, operations, and tactical applications comes from knowing what CI can and cannot do and how it fits into the spectrum of widely used market analysis techniques. Data from a 2007 CI benchmarking survey from Fuld & Company, ‘From Stick Fetchers to World Class™’ indicates that CI is part of many pharmaceutical and biotechnology companies. The pharmaceutical and biotech companies are spending anywhere from less than $100,000 dollars to more than $2 million dollars. The years of experience the information in this guide represents is intended for anyone in the life sciences using CI, such as brand managers, R&D managers, regulatory affairs, or investor relations, who is either learning about CI for the first time or building on information they already know. Highlights:



  • Definition, uses, and anecdotes of what CI is from veteran CI professionals

  • Tips, experience, and insight about the use of the Internet for CI

  • How to use CI as part of strategy analysis

  • Information about how CI software can help a CI research and analysis process

  • Evaluating and improving the quality and efficiency of a CI process

  • Glossary of over 100 CI terms
The information that follows has been collected from Fuld & Company thanks to the help and contributions from many of the staff. Fuld & Company opened its doors in 1979 and is the first and oldest competitive intelligence firm. Leonard Fuld, founder and president, is a pioneer of CI. The launch of the Pharma-Healthcare I3® (Internet Intelligence Index), a comprehensive online index of over 250 CI links, in January 2007, is just one of the many innovative intelligence resources the firm has created. Other CI resources created include intelligence-gathering techniques and books. Mr. Fuld has also continuously shared his innovative thinking for the last 30 years in Academy of Competitive Intelligence classes, lectures around the world, and with his staff.  
 


RELATED REPORTS

Cancer Vaccines: Market Forecasts, New Developments and Pipeline Analysis

Cancer Vaccines: Market Forecasts, New Developments and Pipeline Analysis

  • $ 3 995
  • November 2008

It is the general consensus of scientists that cancer vaccines will become a reality. Overall the cancer treatment market continues to grow and this demand sets the stage for vaccine products.Several promising vaccines: the propholactic Gardasil has created a pathway for new vaccine products. M-Vax, ...

Industries : Pharmaceutical

The Global Vaccines Market 2008-2023

The Global Vaccines Market 2008-2023

  • $ 2 501
  • August 2008

The period 2008-2023 will see a vaccine “boost”. There will be a new resurgence in the sales and utilisation of vaccines. Are you prepared for this? You should be. During this period, vaccines will be one of the fastest growing segments of the pharmaceutical market. Vaccine revenues will increas ...

Industries : Pharmaceutical

Global Pharmaceutical Market Forecast to 2012

Global Pharmaceutical Market Forecast to 2012

  • $ 2 100
  • October 2008

The global pharmaceutical market is expected to earn over a trillion dollar in revenues by 2012 and according to ````Global Pharmaceutical Market Forecast to 2012”, our new research report, the market will witness a number of changes impacting its course of growth. These include the shift of growt ...

Industries : Pharmaceutical

Global Vaccine Market Forecast to 2012

Global Vaccine Market Forecast to 2012

  • $ 2 200
  • October 2008

“Global Vaccine Market Forecast to 2012”, our new research report, states that vaccines, which were earlier thought as a low margin, low growth industry, have emerged as one of the most lucrative segments in the pharmaceutical industry. With a projected CAGR growth of over 16% in the next five y ...

Industries : Pharmaceutical

The Market for In Vitro Toxicology Testing

The Market for In Vitro Toxicology Testing

  • $ 4 850
  • March 2007

This report contains: An overview of the in-vitro toxicology testing market, explaining basic principles and practices, definitions, classes of tests, and the different types of toxicology; A technical overview that describes toxicology testing strategies, the various toxicology categories, and alte ...

Industries : Pharmaceutical

The Global Pain Therapeutics Market, 3rd Edition

The Global Pain Therapeutics Market, 3rd Edition

  • $ 3 500
  • October 2008
  • 438 pages

One in five people suffer from moderate to severe chronic pain, and one in three is unable or less able to maintain an independent lifestyle due to their pain. Between 50 and 60 percent of people with chronic pain are less able or unable to exercise, sleep normally, perform household chores, attend ...

Industries : Pharmaceutical

Indian Generics 2008-2012: The Growing Threat to Westernised Markets

Indian Generics 2008-2012: The Growing Threat to Westernised Markets

  • $ 3 120
  • October 2008
  • 138 pages

Indian pharmaceutical companies are grabbing headlines on an almost daily basis and are increasingly carving out market shares for themselves in the US and many other markets around the world. Several leading Indian pharmaceutical companies have applied themselves to the challenge of entering Weste ...

Industries : Pharmaceutical

Evidence-Based Medicine: Current Use and Future Impact on Global Clinical and Reimbursement Practices

Evidence-Based Medicine: Current Use and Future Impact on Global Clinical and Reimbursement Practices

  • $ 2 999
  • October 2008
  • 181 pages

Evidence-based medicine is defined as an attempt to use standards from scientifically-collected evidence to improve medical practices by assessing risks and benefits of treatments and/or the lack of treatments. The term can be taken to cover a wide variety of recommendations and guidelines, as well ...

Industries : Pharmaceutical

Cancer Therapeutics:  Market Insight and R&D Pipeline Analysis

Cancer Therapeutics: Market Insight and R&D Pipeline Analysis

  • $ 3 500
  • October 2008
  • 318 pages

Objectives and ScopeThe intention of this study is to provide a detailed and thorough analysis of the present and future global market for cancer therapeutics. This report analyzes in detail the markets for colorectal cancer, prostate cancer, lung cancer, breast cancer, leukemia and non-Hodgkin’s ...

Industries : Pharmaceutical

Drug Delivery Technologies: Current Market Dynamics, Future Market Opportunities and Lifecycle Strategies

Drug Delivery Technologies: Current Market Dynamics, Future Market Opportunities and Lifecycle Strategies

  • $ 3 500
  • October 2008
  • 283 pages

The drug delivery industry has in recent years become a key partner for pharmaceutical companies in their efforts to maximize the patent lives of successful products. Drug delivery companies not only stand to benefit from patent expiry by providing their reformulation services to pharmaceutical comp ...

Industries : Pharmaceutical

24/7 Customer Service

Contact Shadi now !

reportlinker.com © Copyright 2009. All rights reserved

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.